Generated by GPT-5-mini| Gonzales v. Raich | |
|---|---|
| Case name | Gonzales v. Raich |
| Citation | 545 U.S. 1 (2005) |
| Decided | June 6, 2005 |
| Docket | 03-1454 |
| Court | Supreme Court of the United States |
| Majority | John G. Roberts Jr. |
| Dissent | Antonin Scalia |
| Laws applied | Commerce Clause; Controlled Substances Act |
Gonzales v. Raich
Gonzales v. Raich was a 2005 decision of the Supreme Court of the United States addressing federal authority under the Commerce Clause to regulate locally cultivated cannabis used for purported medical cannabis purposes, brought by plaintiffs including Angel Raich and Diane Monson against respondents such as Alberto Gonzales, then Attorney General of the United States. The case arose amid state-level reform efforts exemplified by ballot initiatives like California’s Proposition 215 and legislative actions in states such as California, raising tensions between federal enforcement under the Controlled Substances Act and state medical-use regimes. The ruling drew participation from amici curiae including American Civil Liberties Union, National Rifle Association, and several state attorneys general, and has been cited in later disputes involving federal regulatory authority and federalism debates in contexts such as Affordable Care Act jurisprudence and interstate commerce regulation.
In the late 1990s and early 2000s, proponents of medical-use reform advanced ballot measures like California Proposition 215 and legislative frameworks in jurisdictions including Oregon, Washington (state), and Alaska (state). Plaintiffs Angel Raich and Diane Monson relied on homegrown marijuana for medical conditions and obtained injunctions against federal seizure under local state law claims. Federal enforcement actions under the Controlled Substances Act were initiated by agencies led by Drug Enforcement Administration administrators and the United States Department of Justice, with prosecutorial authority exercised by the United States Attorney General. Litigation proceeded through the United States Court of Appeals for the Ninth Circuit, which interpreted precedents including Wickard v. Filburn and United States v. Lopez, before reaching the Supreme Court.
The Court framed whether Congress, pursuant to the Commerce Clause and its power to regulate interstate commerce, may criminalize the production and consumption of marijuana in compliance with state law when that activity is purely intrastate and noncommercial. Related doctrinal questions implicated precedents such as Wickard v. Filburn (aggregation doctrine), Gonzales v. Oregon (federalism and the role of the Attorney General), and United States v. Lopez (limits on congressional power). Petitioners argued for national uniformity under the Controlled Substances Act and the need to prevent diversion into interstate illicit drug trafficking, while respondents invoked Tenth Amendment principles and state-sanctioned medical regimes.
The Court, in an opinion authored by John G. Roberts Jr., upheld congressional power under the Commerce Clause to prohibit local cultivation and possession of marijuana even when state law authorized medical use. The majority concluded that Congress could rationally find that even noncommercial, intrastate cultivation could affect the interstate market for cannabis and therefore fall within federal regulatory authority, relying on precedent such as Wickard v. Filburn and interpreting limits articulated in United States v. Lopez and United States v. Morrison. The decision reversed the judgment of the United States Court of Appeals for the Ninth Circuit and reinstated enforcement authority under the Controlled Substances Act.
The majority, led by John G. Roberts Jr., emphasized congressional findings about market effects and the need to prevent diversion to interstate markets, citing precedents including Wickard v. Filburn, Heart of Atlanta Motel, Inc. v. United States, and Gibbons v. Ogden. Separate opinions addressed the scope of federal power relative to state initiatives like California Proposition 215. Dissenting justices, notably Antonin Scalia joined by other dissenters, argued that the decision eroded limits on federal power established in United States v. Lopez and United States v. Morrison, warning of the implications for the Tenth Amendment and state sovereignty. Concurring and dissenting views invoked figures and doctrines connected to federalism debates, referencing scholars and actors such as James Madison, Alexander Hamilton, and institutional actors like state attorneys general and the United States Congress.
Gonzales v. Raich has been cited in subsequent litigation involving federal regulatory reach, including cases arising under the Affordable Care Act, federal administrative law, and disputes over federal criminal enforcement against state-legal activities in sectors such as cannabis industry regulation. The decision influenced policy discussions in jurisdictions including Colorado, Washington (state), Oregon, and California, prompting dialogues among executives such as state governors and federal officials including successive United States Attorneys General. It also informed Congressional action and executive guidance, including memoranda from administrations and coordination among agencies like the Drug Enforcement Administration and Department of Justice concerning enforcement priorities. Scholars in constitutional law and observers from organizations like the American Bar Association and Brookings Institution have treated the decision as central to modern commerce-clause jurisprudence, and courts have grappled with its reach in contexts involving environmental regulation, medical practice regulation, and interstate markets. The ongoing evolution of state legislation, ballot measures, and federal policy continues to test the balance between national regulatory schemes and state-level reform movements exemplified by the parties and controversies in this case.
Category:United States Supreme Court cases Category:United States Supreme Court cases of the Roberts Court